| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.800 | strong | 0.972 | 5 | 13 | 1990 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.800 | strong | 0.973 | 3 | 2 | 1993 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.800 | strong | 0.966 | 0 | 1 | 1993 | 2020 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.800 | strong | 0.971 | 0 | 2 | 1993 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.700 | None | 0.983 | 0 | 3 | 1997 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.700 | None | 0.985 | 0 | 5 | 2002 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.947 | 0 | 7 | 1989 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.976 | 0 | 5 | 2002 | 2020 | ||||||||
|
BUB1 mitotic checkpoint serine/threonine kinase | 0.528 | 0.731 | 4.9E-09 |
|
disease | 0.700 | None | 1.000 | 0 | 1 | 2000 | 2018 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.700 | limited | 0.885 | 0 | 1 | 2003 | 2019 | ||||||||
|
DCC netrin 1 receptor | 0.471 | 0.808 | 0.99 |
|
disease | 0.700 | None | 0.946 | 0 | 1 | 1990 | 2019 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.660 | None | 1.000 | 0 | 8 | 2000 | 2018 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.640 | None | 1.000 | 1 | 4 | 1996 | 2017 | ||||||||
|
mutY DNA glycosylase | 0.521 | 0.769 | 1.3E-18 |
|
disease | 0.500 | strong | 0.947 | 22 | 9 | 2002 | 2019 | ||||||||
|
PMS1 homolog 2, mismatch repair system component | 0.484 | 0.808 | 4.5E-27 |
|
disease | 0.500 | strong | 0.967 | 0 | 1 | 1998 | 2020 | ||||||||
|
axin 2 | 0.507 | 0.692 | 0.57 |
|
disease | 0.500 | None | 0.905 | 0 | 3 | 2001 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.500 | None | 0.938 | 0 | 4 | 2000 | 2019 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.500 | None | 0.975 | 0 | 3 | 1994 | 2020 | |||||||||
|
cytochrome c oxidase subunit I | 0.441 | 0.885 |
|
disease | 0.500 | None | 1.000 | 0 | 2 | 1994 | 2019 | |||||||||
|
mutL homolog 3 | 0.582 | 0.538 | 4.9E-08 |
|
disease | 0.500 | None | 0.833 | 0 | 1 | 2000 | 2019 | ||||||||
|
MCC regulator of WNT signaling pathway | 0.568 | 0.731 | 4.7E-16 |
|
disease | 0.500 | None | 0.929 | 0 | 2 | 1991 | 2018 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.490 | None | 1.000 | 0 | 1 | 2014 | 2019 | ||||||||
|
DLC1 Rho GTPase activating protein | 0.529 | 0.731 | 1.00 |
|
disease | 0.450 | None | 1.000 | 0 | 1 | 2013 | 2019 | ||||||||
|
platelet derived growth factor receptor like | 0.769 | 0.385 | 1.2E-14 |
|
disease | 0.410 | None | 1.000 | 0 | 1 | 1995 | 2010 | ||||||||
|
NADH dehydrogenase, subunit 4L (complex I) | 0.805 | 0.308 |
|
disease | 0.400 | None | 0 | 1 |